[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Article
March 2, 1984

Prophylactic Sulfamethoxazole and Trimethoprim in Ventriculoperitoneal Shunt Surgery: A Double-blind, Randomized, Placebo-Controlled Trial

Author Affiliations

From the Divisions of Infectious Diseases (Drs Wang and Prober), and Neurosurgery (Drs Hendrick, Hoffman, and Humphreys), The Hospital for Sick Children, Toronto.

JAMA. 1984;251(9):1174-1177. doi:10.1001/jama.1984.03340330032019
Abstract

We conducted a randomized, double-blind, placebo-controlled study during a 30-month period to determine whether sulfamethoxazole and trimethoprim would decrease the incidence of infections occurring after ventriculoperitoneal shunt surgery. Of the 120 patients who completed the study according to protocol, 55 received sulfamethoxazole and trimethoprim and 65 received placebo. The incidence of CSF infection in the group receiving sulfamethoxazole and trimethoprim (4/55) was similar to that in the control group (5/65). There was a trend toward earlier identification of infections in the sulfamethoxazole and trimethoprim group (mean, 24.5 days) compared with the control group (mean, 47 days). There was no difference between infected and uninfected patients with respect to frequency of purported risk factors for infection, including history of shunt infection, history of recent myelomeningocele repair, and type and duration of shunt surgery. The incidence of shunt malfunction was similar in uninfected patients receiving antibiotic prophylaxis (18/51) compared with that of patients receiving placebo (23/60). We did not find that the perioperative use of sulfamethoxazole and trimethoprim reduced the incidence of shunt infection or malfunction.

(JAMA 1984;251:1174-1177)

References
1.
Haines SJ:  Systemic antibiotic prophylaxis in neurological surgery .  Neurosurgery 1980; 6:355-361.Crossref
2.
Forrest DM, Cooper DGW:  Complications of ventriculoatrial shunts: A review of 455 cases .  J Neurosurg 1968;29:506-512.Crossref
3.
Schoenbaum SC, Gardner P, Shillito J:  Infections of cerebrospinal fluid shunts: Epidemiology, clinical manifestations, and therapy .  J Infect Dis 1975;131:543-552.Crossref
4.
Shurtleff DB, Christie D, Foltz EL:  Ventriculoauriculostomy-associated infection: A 12-year study .  J Neurosurg 1971;35:686-694.Crossref
5.
Venes JL:  Control of shunt infection: Report of 150 consecutive cases .  J Neurosurg 1976;45:311-314.Crossref
6.
McLone DG, Czyzewski D, Raimondi AJ, et al:  Central nervous system infections as a limiting factor in the intelligence of children with myelomeningocele .  Pediatrics 1982;70:338-342.
7.
George R, Leibrock L, Epstein M:  Longterm analysis of cerebrospinal fluid shunt infections: A 25-year experience .  J Neurosurg 1979;51:804-811.Crossref
8.
Bayston R, Lari J:  A study of the sources of infection in colonized shunts .  Dev Med Child Neurol 1974;16( (supp 32) ):16-22.Crossref
9.
Ignelzi RJ, Kirsch WM:  Followup analysis of ventriculoperitoneal and ventriculoatrial shunts for hydrocephalus .  J Neurosurg 1975; 42:679-682.Crossref
10.
Tsingoglou S, Forrest DM:  A technique for the insertion of Holter ventriculoatrial shunt for infantile hydrocephalus .  Br J Surg 1971;58:367-372.Crossref
11.
Ajir F, Levin AB, Duff TA:  Effect of prophylactic methicillin in cerebrospinal fluid shunt infections in children .  Neurosurgery 1981; 9:6-8.Crossref
12.
Malis LI:  Prevention of neurosurgical infection by intraoperative antibiotics .  Neurosurgery 1979;5:339-343.Crossref
13.
McCullough DC, Kane JG, Presper JH, et al:  Antibiotic prophylaxis in ventricular shunt surgery: I. Reduction of operative infection rates with methicillin .  Child's Brain 1980;7:182-189.
14.
McLaurin RL:  Infected cerebrospinal fluid shunts .  Surg Neurol 1973;1:191-195.
15.
Salmon JH:  Adult hydrocephalus-evaluation of shunt therapy in 80 patients .  J Neurosurg 1972;37:423-428.Crossref
16.
Savitz MH, Katz SS:  Rationale for prophylactic antibiotics in neurosurgery .  Neurosurgery 1981;9:142-144.Crossref
17.
O'Brien MO, Parent A, Davis B:  Management of ventricular shunt infections .  Child's Brain 1979;5:304-309.
18.
Yu HC, Patterson RH:  Prophylactic antimicrobial agents after ventriculoatriostomy for hydrocephalus .  J Pediatr Surg 1973;8:881-885.Crossref
19.
Weiss SR, Raskind R:  Further experience with the ventriculoperitoneal shunt: Prophylactic antibiotics .  Int Surg 1970;53:300-303.
20.
Bayston R:  Antibiotic prophylaxis in shunt surgery .  Dev Med Child Neurol 1975;17( (suppl 35) ):99-103.Crossref
21.
Haines SJ, Taylor F:  Prophylactic methicillin for shunt operations: Effects on incidence of shunt malfunction and infection .  Child's Brain 1982;9:10-22.
22.
Archer GL:  Antimicrobial susceptibility and selection of resistance among Staphylococcus epidermidis isolates recovered from patients with infections of indwelling foreign devices .  Antimicrob Agents Chemother 1978;14:353-359.Crossref
23.
Sabath LD, Garner C, Wilcox C, et al:  Susceptibility of Staphylococcus aureus and Staphylococcus epidermidis to 65 antibiotics .  Antimicrob Agents Chemother 1976;9:962-969.Crossref
24.
Price SB, Flournoy DJ:  Comparison of antimicrobial susceptibility patterns among coagulase-negative staphylococci .  Antimicrob Agents Chemother 1982;21:436-440.Crossref
25.
Wilkinson PJ, Reeves DS:  Tissue penetration of trimethoprim and sulphonamides .  J Antimicrob Chemother 1979;5( (supp B) ):159-168.Crossref
26.
Goodwin CS, Bucens MC, Davis RC, et al:  High dose co-trimoxazole and its penetration through uninflamed meninges .  Med J Aust 1981; 2:24-27.
27.
Kirwan WO:  Cerebrospinal fluid cotrimoxazole levels .  J Irish Med Assoc 1974;67:76-77.
28.
Svedham A, Iwarson S:  Cerebrospinal fluid concentrations of trimethoprim during oral and parenteral treatment .  J Antimicrob Chemother 1979;5:717-720.Crossref
29.
Wang EEL, Prober CG:  Ventricular cerebrospinal fluid concentrations of trimethoprimsulphamethoxazole .  J Antimicrob Chemother 1983;11:385-389.Crossref
30.
Myers MG, Schoenbaum SC:  Shunt fluid aspiration: An adjunct in the diagnosis of cerebrospinal fluid shunt infection .  Am J Dis Child 1975;129:220-222.
31.
Sekhar LN, Moossy J, Guthkelch AN:  Malfunctioning ventriculoperitoneal shunts: Clinical and pathological features .  J Neurosurg 1982;56:411-416.Crossref
32.
Fokes EC:  Occult infections of ventriculoatrial shunts .  J Neurosurg 1970;33:517-523.Crossref
33.
Everett ED, Eickhoff TC, Simon RH:  Cerebrospinal fluid shunt infections with anaerobic diphtheroids (Propionibacterium species) .  J Neurosurg 1976;44:580-584.Crossref
34.
Beeler BA, Crowder JG, Smith JW, et al:  Propionibacterium acnes: Pathogen in central nervous system shunt infection. Report of three cases including immune complex glomerulonephritis .  Am J Med 1976;61:935-938.Crossref
×